BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16709847)

  • 1. Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC.
    Maekawa A; Schmidt B; Fazekas de St Groth B; Sanejouand YH; Hogg PJ
    J Immunol; 2006 Jun; 176(11):6873-8. PubMed ID: 16709847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain swapping of CD4 upon dimerization.
    Sanejouand YH
    Proteins; 2004 Oct; 57(1):205-12. PubMed ID: 15326605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox exchange of the disulfides of human two-domain CD4 regulates the conformational dynamics of each domain, providing insight into its mechanisms of control.
    Owen GR; Le D; Stoychev S; Cerutti NM; Papathanasopoulos M
    Biochem Biophys Res Commun; 2018 Mar; 497(2):811-817. PubMed ID: 29470989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced monomeric CD4 is the preferred receptor for HIV.
    Matthias LJ; Azimi I; Tabrett CA; Hogg PJ
    J Biol Chem; 2010 Dec; 285(52):40793-9. PubMed ID: 20974843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.
    Cerutti N; Killick M; Jugnarain V; Papathanasopoulos M; Capovilla A
    J Biol Chem; 2014 Apr; 289(15):10455-10465. PubMed ID: 24550395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triggering of T cell activation via CD4 dimers.
    Moldovan MC; Sabbagh L; Breton G; Sékaly RP; Krummel MF
    J Immunol; 2006 May; 176(9):5438-45. PubMed ID: 16622011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 dimers constitute the functional component required for T cell activation.
    Moldovan MC; Yachou A; Lévesque K; Wu H; Hendrickson WA; Cohen EA; Sékaly RP
    J Immunol; 2002 Dec; 169(11):6261-8. PubMed ID: 12444132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
    Lindstedt R; Monk N; Lombardi G; Lechler R
    J Immunol; 2001 Jan; 166(2):800-8. PubMed ID: 11145653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC.
    Langedijk JP; Puijk WC; van Hoorn WP; Meloen RH
    J Biol Chem; 1993 Aug; 268(23):16875-8. PubMed ID: 8043041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD4 Metastability Is a Function of the Allosteric Disulfide Bond in Domain 2.
    Owen GR; Channell JA; Forsyth VT; Haertlein M; Mitchell EP; Capovilla A; Papathanasopoulos M; Cerutti NM
    Biochemistry; 2016 Apr; 55(15):2227-37. PubMed ID: 27009680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Several indirect methods for analysis of CD4 self-association and its function in stable CD4-MHC-II binding].
    Xiao H; Li S; Shen BF; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):239-43. PubMed ID: 16013482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.
    König R; Shen X; Germain RN
    J Exp Med; 1995 Sep; 182(3):779-87. PubMed ID: 7650484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
    Wang JH; Meijers R; Xiong Y; Liu JH; Sakihama T; Zhang R; Joachimiak A; Reinherz EL
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10799-804. PubMed ID: 11535811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
    Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
    J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response.
    Pan S; Trejo T; Hansen J; Smart M; David CS
    J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4.
    Boen E; Crownover AR; McIlhaney M; Korman AJ; Bill J
    J Immunol; 2000 Aug; 165(4):2040-7. PubMed ID: 10925287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GB1 amyloid fibril: recruitment of the peripheral beta-strands of the domain swapped dimer into the polymeric interface.
    Louis JM; Byeon IJ; Baxa U; Gronenborn AM
    J Mol Biol; 2005 May; 348(3):687-98. PubMed ID: 15826664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain.
    McAuley A; Jacob J; Kolvenbach CG; Westland K; Lee HJ; Brych SR; Rehder D; Kleemann GR; Brems DN; Matsumura M
    Protein Sci; 2008 Jan; 17(1):95-106. PubMed ID: 18156469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.